{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:47:42Z","timestamp":1761648462247,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.aohep.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:39:36Z","timestamp":1598305176000},"page":"583-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!"],"prefix":"10.1016","volume":"19","author":[{"given":"Kevork Minas","family":"Peltekian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.07.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.08.066","article-title":"Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population","author":"Zambrano-Huailla","year":"2020","journal-title":"Ann Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2020.07.011_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol."},{"issue":"2","key":"10.1016\/j.aohep.2020.07.011_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1155\/2006\/452942","article-title":"Percutaneous liver biopsy: reflections and refinements","volume":"20","author":"Ghent","year":"2006","journal-title":"Can J Gastroenterol."},{"issue":"12","key":"10.1016\/j.aohep.2020.07.011_bib0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jclinpath-2013-201440","article-title":"How often do our liver core biopsies reach current definitions of adequacy?","volume":"66","author":"Fryer","year":"2013","journal-title":"J Clin Pathol."},{"issue":"7","key":"10.1016\/j.aohep.2020.07.011_bib0025","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1016\/j.aohep.2020.07.011_bib0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut."},{"issue":"2","key":"10.1016\/j.aohep.2020.07.011_bib0035","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep."},{"issue":"9","key":"10.1016\/j.aohep.2020.07.011_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.04.062","article-title":"Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients with Chronic Liver Diseases: A Systematic Review and Meta-analysis","volume":"17","author":"Stafylidou","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2020.07.011_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med."}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120301587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120301587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:41:22Z","timestamp":1761648082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120301587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1665268120301587"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.07.011","relation":{},"ISSN":["1665-2681"],"issn-type":[{"type":"print","value":"1665-2681"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"For fatty liver diseases, it is time to utilize non-invasive fibrosis tests to predict liver related events rather than just histological stages of hepatic fibrosis!","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}